determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the individual …

This position paper provides a comprehensive guide for optimal follow-up of patients with
acute pulmonary embolism (PE), covering multiple relevant aspects of patient counselling. It …

Objective To evaluate the effects of therapeutic heparin compared with prophylactic heparin
among moderately ill patients with covid-19 admitted to hospital wards. Design Randomised …

Introduction Venous thromboembolism (VTE) is a leading cause of cardiovascular morbidity
and mortality. The majority of VTE events are hospital‐associated. In 2008, the …

Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has affected over 30 million globally to date. Although …

Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …

Background Pulmonary endothelial injury and microcirculatory thromboses likely contribute
to hypoxemic respiratory failure, the most common cause of death, in patients with COVID‐19…

Background Women with a history of venous thromboembolism (VTE) have a 2% to 10%
absolute risk of VTE recurrence during subsequent pregnancies. Therefore, current guidelines …

Upon activation, platelets release a powerful cocktail of soluble and vesicular signals,
collectively termed the "platelet releasate" (PR). Although several studies have used qualitative/…

Background Heparin, in addition to its anticoagulant properties, has anti-inflammatory and
potential anti-viral effects, and may improve endothelial function in patients with Covid-19. …